In China, researchers supposedly develop a new ‘controllable, reversible’ gene-editing process.
Using CRISPR technology, scientists from the Chinese Academy of Sciences (CAS) are said to have devised a new "controllable, reversible, and safer" gene-editing strategy.
According to an article published on Wednesday in the South China Morning Post newspaper, the Cas13d-N2V8 system demonstrated a considerable reduction in the amount of off-target genes and no observable collateral damage in cell lines and somatic cells, indicating its future potential.
According to the researchers, the novel strategy using the Cas13 enzyme to target RNA is safer because RNAs are transient molecules that only exist in the cell for a brief amount of time and are not integrated into the genome.
"The Cas13 gene editing approach is safer, and the effects are more manageable and short-lived," said Yang H...